Relationships among immunoglobulin markers in Graves' disease. - Suppr | 超能文献

Relationships among immunoglobulin markers in Graves' disease.

作者信息

Ozawa Y, Maciel R M, Chopra I J, Solomon D H, Beall G N

出版信息

J Clin Endocrinol Metab. 1979 Mar;48(3):381-7. doi: 10.1210/jcem-48-3-381.

DOI:10.1210/jcem-48-3-381

Abstract

摘要

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

文档翻译

学术文献翻译模型，支持多种主流文档格式。

相似文献

1

Relationships among immunoglobulin markers in Graves' disease.

J Clin Endocrinol Metab. 1979 Mar;48(3):381-7. doi: 10.1210/jcem-48-3-381.

2

The long-acting thyroid stimulatory: is it of importance in Graves' disease.长效甲状腺刺激素：它在格雷夫斯病中重要吗？

N Z Med J. 1975 Jan 8;81(531):18-21.

3

Correlation of long-acting thyroid stimulator with serum levels of tri-iodothyronine, thyroxine and thyrotropin in Graves' disease.长效甲状腺刺激素与格雷夫斯病患者血清三碘甲状腺原氨酸、甲状腺素及促甲状腺激素水平的相关性

J Assoc Physicians India. 1975 Feb;23(2):111-4.

4

[Simultaneous determination of thyrotropic hormone and long-acting thyroid stimulator in the plasma of patients with Graves' disease].[格雷夫斯病患者血浆中促甲状腺激素和长效甲状腺刺激素的同步测定]

Klin Wochenschr. 1971 May 1;49(9):554-7. doi: 10.1007/BF01487994.

5

Correlation between thyroid stimulators and 3,5,3'-triiodothyronine suppressibility in patients during treatment for hyperthyroidism with thionamide drugs: comparison of assays by thyroid-stimulating and thyrotropin-displacing activities.硫酰胺类药物治疗甲亢患者时甲状腺刺激物与3,5,3'-三碘甲状腺原氨酸抑制性之间的相关性：基于甲状腺刺激活性和促甲状腺激素替代活性检测方法的比较

J Clin Endocrinol Metab. 1979 Apr;48(4):706-11. doi: 10.1210/jcem-48-4-706.

6

Relationship of long-acting thyroid stimulator to the clinical features and course of Graves' disease.长效甲状腺刺激素与格雷夫斯病临床特征及病程的关系。

Am J Med. 1967 Oct;43(4):486-98. doi: 10.1016/0002-9343(67)90175-1.

7

Hypothyroidism with unusual features following propylthiouracil therapy of Graves' disease.

Am J Med Sci. 1972 Dec;264(6):499-505. doi: 10.1097/00000441-197212000-00010.

8

[Simultaneous determination of thyreotropic hormone and long-acting thyroid stimulator in the plasma of Basedow patients].[同时测定巴塞多氏病患者血浆中的促甲状腺激素和长效甲状腺刺激素]

Orv Hetil. 1970 Dec 27;111(52):3067-70.

9

Absence of thyroid-stimulating antibody and long acting thyroid stimulator in relatives of Graves' disease patients.

J Clin Endocrinol Metab. 1981 Sep;53(3):651-3. doi: 10.1210/jcem-53-3-651.

10

[Long-acting thyroid stimulator (LATS), thyrotropin (TSH) and the pathogenesis of hyperthyroidism].[长效甲状腺刺激素（LATS）、促甲状腺激素（TSH）与甲状腺功能亢进症的发病机制]

Nord Med. 1968 Dec 5;80(49):1651-7.

引用本文的文献

1

The thyrotrophin receptor.促甲状腺激素受体

Springer Semin Immunopathol. 1982;5(4):413-31. doi: 10.1007/BF01857428.

2

Monoclonal antibodies to the thyrotropin receptor: the identification of blocking and stimulating antibodies.促甲状腺激素受体单克隆抗体：阻断性抗体与刺激性抗体的鉴定

J Endocrinol Invest. 1982 Sep-Oct;5(5):293-301. doi: 10.1007/BF03350517.

3

Clinical significance of thyrotrophin binding inhibitor immunoglobulins in patients with Graves' disease and various types of thyroiditis.促甲状腺素结合抑制性免疫球蛋白在格雷夫斯病及各类甲状腺炎患者中的临床意义

Korean J Intern Med. 1987 Jan;2(1):112-9. doi: 10.3904/kjim.1987.2.1.112.